Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
Health Technology » Biotechnology
|VRTX||Vertex Pharmaceuticals, Inc.||0.58%||288.98||1.9%||$508.85m|
|GILD||Gilead Sciences, Inc.||-0.03%||62.34||1.0%||$477.30m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.20%||596.56||2.6%||$452.80m|
|SNSS||Sunesis Pharmaceuticals, Inc.||3.00%||3.78||0.7%||$264.24m|
|CRSP||CRISPR Therapeutics AG||10.68%||70.60||0.6%||$192.52m|
|BMRN||BioMarin Pharmaceutical, Inc.||1.62%||86.36||4.2%||$117.47m|
|EXAS||EXACT Sciences Corp.||7.95%||44.40||17.7%||$102.51m|
|NTLA||Intellia Therapeutics, Inc.||16.98%||63.18||2.2%||$99.79m|
|AXSM||Axsome Therapeutics, Inc.||1.40%||41.21||1.8%||$99.33m|
bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in the development of potential gene therapies for severe genetic diseases and cancer. Its integrated product platform includes gene therapy, cancer immunotherapy and gene editing. Its product pipeline includes Lenti-D, LentiGlobin, BCL11a shRNA, bb2121, and bb21217. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Somerville, MA.